Overview: Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for oncology and other diseases, with a market cap of $262.74 ...
We recently compiled a list of the 10 Best Penny Stocks To Buy According to the Media. In this article, we are going to take a look at where Compass, Inc. (NYSE:COMP) stands against the other penny ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback